FDA to conduct workshop on risk minimization programs
How should risk minimization programs be designed to promote better health care? That's the focus of an upcoming two-day workshop to be held by the FDA.
How should risk minimization programs be designed to promote better health care? That's the focus of an upcoming two-day workshop to be held by the FDA. The agency said it is particularly interested in looking at reminder systems that prompt health professionals and patients about the prescribing, dispensing, or use of products in ways that minimize risk. The workshop will be held June 25-26 at the AHRQ office in Rockville, Md. Comments to FDA should be submitted by July 31. For more information about the event, click
Recent Videos
Related Content
